GuideAI Health (NEOE:GDAI) EV-to-FCF: (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NEOE:GDAI GuideAI Health Corp NEOE:GDAI
11 GF Score
Price C$1.00
View Full Analysis

What is GuideAI Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, GuideAI Health's Enterprise Value is C$56.90 Mil. GuideAI Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was C$0.00 Mil. Therefore, GuideAI Health's EV-to-FCF for today is .

The historical rank and industry rank for GuideAI Health's EV-to-FCF or its related term are showing as below:

NEOE:GDAI' s EV-to-FCF Range Over the Past 10 Years
Min: -58   Med: 0   Max: 0
Current: -58
NEOE:GDAI's EV-to-FCF is ranked worse than
100% of 405 companies
in the Healthcare Providers & Services industry
Industry Median: 17.83 vs NEOE:GDAI: -58.00

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-27), GuideAI Health's stock price is C$1.00. GuideAI Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was C$-0.021. Therefore, GuideAI Health's PE Ratio (TTM) for today is At Loss.

GuideAI Health  (NEOE:GDAI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

GuideAI Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.00/-0.021
=At Loss

GuideAI Health's share price for today is C$1.00.
GuideAI Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.021.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

GuideAI Health EV-to-FCF Related Terms

GuideAI Health EV-to-FCF Historical Data

* Premium members only.

The historical data trend for GuideAI Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GuideAI Health EV-to-FCF Chart

GuideAI Health Annual Data
Trend Jun23 Jun24 Jun25
EV-to-FCF
0.00 0.00 0.00

GuideAI Health Quarterly Data
Jun23 Jun24 Mar25 Jun25 Mar26
EV-to-FCF 0.00 0.00 0.00 0.00 0.00

NEOE:GDAI vs VEEV, BTSG, HQY: EV-to-FCF Comparison

For the Health Information Services subindustry, GuideAI Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GuideAI Health EV-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GuideAI Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where GuideAI Health's EV-to-FCF falls into.


NEOE:GDAI
11GF Score
GuideAI Health Corp NEOE:GDAI
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GuideAI Health EV-to-FCF Calculation

GuideAI Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=56.897/0
=

GuideAI Health's current Enterprise Value is C$56.90 Mil.
GuideAI Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GuideAI Health Business Description

Address 550 Burrard Street, Suite 2300, Vancouver, BC, CAN, V6C 2B5
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.
11GF Score

Get the complete analysis for NEOE:GDAI

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.00
Price